Year 2011

Autumn Brings Personnel Changes In Geneva

The annual summer shuffle of the mission staff in Geneva has been particularly active this year for those with responsibility for intellectual property rights, with several key diplomats packing their bags, and new ones arriving.

Alto Funcionário Discute Sobre Renúncia Ao Seu Cargo Na ANVISA, No Brasil, Devido à Política Sobre Patentes

Luis Carlos Wanderley Lima, funcionário sênior responsável pela política brasileira que expressa a opinião do Ministério da Saúde no referente à análise de pedidos de patente que possam ocasionar um impacto na saúde pública, renunciou recentemente em protesto contra as modificações na mencionada política. Em uma sessão de perguntas e respostas com a Intellectual Property Watch, ele conversou com relação a sua decisão.

UN Highlights IP Rights For Indigenous Peoples’ Day

In recognition of the International Day of the World's Indigenous Peoples, the secretary of the United Nations on 9 August raised the complex issue of intellectual property rights and indigenous knowledge. The Director General of the UN World Intellectual Property Organization also issued a message straddling the issue of IP rights and community ownership of traditional knowledge and resources.

Changes At The Top As RIAA Sees “Bright Future”

The Recording Industry Association of America today announced that Cary Sherman has been named chairman and CEO amid claims that the music industry is looking up. Sherman takes over for Mitch Bainwol, who resigned to become CEO of the Alliance of Automobile Manufacturers.

Promoting Caribbean Intellectual Property Law

Across the world, the Caribbean is renowned for its unique flavors in music and entertainment, its beaches, cricket, and its commonly acclaimed fun and sun. While these are well-deserved, and are sources of just pride, this common perception provides foliage which bars the examination and explanation of the real problems and needs in intellectual property in the Caribbean, writes attorney Abiola Inniss.

Getting The Most Value From Your Patent Claims

Preparing patents is both a science and an art. The science is often easy to recognize, if not always easy to understand. The art of properly expressing that science in the words of a patent claim is harder to evaluate and is more often overlooked, yet is crucial to the value of the patent, write Heather J. DiPietrantonio and Edmund J. Walsh.

US Senate Vote On Patent Reform Expected In September

The United States Senate is expected to hold a vote on a bill to modify US patent law, in part making it more closely aligned with international practices, according to Senate sources. But some are concerned the bill will not end patent fee diversion at the US Patent and Trademark Office.

Myriad Outcome: Winds Shift Again For Gene Patenting In The US

In a long-awaited decision, a United States federal appeals court has decided that US companies can patent breast cancer genes, reversing a previous ruling. The decision was not unanimous, with one of the three judges dissenting. But despite the attention the case has received, the ruling may have little impact on the biotechnology industry, according to analysts.

EU-India Agreement In WTO Dispute Raises Bar For EU Drug Seizures

India and the European Union announced a written agreement yesterday that puts more conditions on EU customs authorities before they can stop shipments of generic pharmaceuticals passing through Europe. No longer is the existence of an EU patent on passing generics sufficient cause to stop shipments. The agreement suspends a World Trade Organization dispute started by India last year.

A Glance At Current Patent Litigation In India

The third amendment of Patents Act 1970, in 2005, was a major breakthrough for Indian IP practice in patents. The current crop of judicial decisions, discussed in this note, has initiated the need to have a critical mass of judicial precedents streamlining law and rules governing patent practice in India, writes Kamakhya Srivastava.